Zoledronic Acid Reduces Osteonecrosis and Anti-Leukemic Efficacy in Murine Models of Acute Lymphoblastic Leukemia Therapy

被引：0
|
作者：
Janke, Laura [1 ]
Kim, Jieun [2 ]
Jenkins, David [3 ]
Payton, Monique A. [3 ]
Relling, Mary V. [3 ]
Karol, Seth E. [4 ]
机构：
[1] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Ctr Vivo Imaging & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA
[4] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-112941
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4029
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia
    Buteyn, Nathaniel J.
    Fatehchand, Kavin
    Santhanam, Ramasamy
    Fang, Huiqing
    Dettorre, Gino M.
    Gautam, Shalini
    Harrington, Bonnie K.
    Henderson, Sally E.
    Merchand-Reyes, Giovanna
    Mo, Xiaokui
    Benson, Don M.
    Carson, William E., III
    Vasu, Sumithira
    Byrd, John C.
    Butchar, Jonathan P.
    Tridandapani, Susheela
    INTERNATIONAL IMMUNOLOGY, 2018, 30 (08) : 375 - 383
  • [32] TPEN exerts selective anti-leukemic efficacy in ex vivo drug-resistant childhood acute leukemia
    Mendivil-Perez, Miguel
    Velez-Pardo, Carlos
    David-Yepes, Gloria E.
    Fox, Javier E.
    Jimenez-Del-Rio, Marlene
    BIOMETALS, 2021, 34 (01) : 49 - 66
  • [33] TPEN exerts selective anti-leukemic efficacy in ex vivo drug-resistant childhood acute leukemia
    Miguel Mendivil-Perez
    Carlos Velez-Pardo
    Gloria E. David-Yepes
    Javier E. Fox
    Marlene Jimenez-Del-Rio
    BioMetals, 2021, 34 : 49 - 66
  • [34] Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia
    Ramsey, Laura B.
    Janke, Laura J.
    Payton, Monique A.
    Cai, Xiangjun
    Paugh, Steven W.
    Karol, Seth E.
    Kamdem, Landry Kamdem
    Cheng, Cheng
    Williams, Richard T.
    Jeha, Sima
    Pui, Ching-Hon
    Evans, William E.
    Relling, Mary V.
    PLOS ONE, 2015, 10 (08):
  • [35] LEUKEMIC HYPOPYON IN ACUTE LYMPHOBLASTIC LEUKEMIA AFTER CESSATION OF THERAPY
    MASERA, G
    CARNELLI, V
    UDERZO, C
    TOSELLI, C
    PEDIATRIC RESEARCH, 1978, 12 (01) : 68 - 68
  • [36] Factors predicting anti-leukemic drug resistance in acute myeloid leukemia (AML).
    Bishop, JF
    Mathews, JP
    Young, GA
    Bradstock, K
    BLOOD, 1996, 88 (10) : 3315 - 3315
  • [37] CD52 and CD20 as potential targets for anti-leukemic immunotherapy in adult acute lymphoblastic leukemia.
    Jagoda, K
    Giebel, S
    Stella-Holowiecka, B
    Krawczyk-Kulis, M
    Holowiecki, J
    BLOOD, 2004, 104 (11) : 184B - 185B
  • [38] Chronic anticonvulsant therapy reduces the efficacy of chemotherapy for childhood acute lymphoblastic leukemia (ALL).
    Relling, MV
    Pui, CH
    Sandlund, JT
    Rivera, GK
    Hancock, ML
    Boyett, JB
    Evans, WE
    BLOOD, 1999, 94 (10) : 289A - 289A
  • [39] Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia
    Goossens, Steven
    Cauwels, Anje
    Pieters, Tim
    De Smedt, Renate
    T'Sas, Sara
    Almeida, Andre
    Daneels, Willem
    Van Vlierberghe, Pieter
    Tavernier, Jan
    HAEMATOLOGICA, 2022, 107 (06) : 1448 - 1453
  • [40] Superior Anti-Leukemic Effects of Combined Acid Ceramidase and Bcl-2 Inhibition in Acute Myeloid Leukemia
    Ung, Johnson
    Tan, Su-Fern
    Shaw, Jeremy
    Fox, Todd
    Kester, Mark
    Feith, David
    Loughran, Thomas, Jr.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S211 - S212
12345